Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
“The main scenario that prompts me to use apoB is when a patient’s traditional lipid panel values are either normal, or even slightly abnormal, but have discrepancy with the quality/quantity of their other comorbid problems.” — Austin Shuxiao, MD
Cardiology September 16th 2025
Consultant360
Vaginal fluid collection via tampon under clinical supervision followed by bisulfite conversion and long-probe quantitative amplified signal assays for methylated DNA marker analysis.
Obstetrics & Gynecology June 4th 2025
MedCentral
Blood biomarker testing offers 91.7% accuracy in detecting amyloid plaques while providing more accessible alternative to cerebrospinal fluid analysis, though confirmation via PET or CSF remains necessary for indeterminate results.
Family Medicine/General Practice May 28th 2025
Cleveland Clinic Journal of Medicine (CCJM)
Conditions that warrant gastrointestinal pathogen panel testing include fever, visible blood in the stool, sepsis, severe abdominal pain, hospitalization, persistent diarrhea (≥ 7 days), advanced age, and immunocompromise.
Emergency Medicine March 5th 2025
“Many factors external to the thyroid gland can modulate these diverse effects, making it difficult to assess the thyroid status of patients solely on clinical grounds.”
Endocrinology, Diabetes, Metabolism March 4th 2025
American Journal of Clinical Pathology (AJCP)
Flow cytometric evaluation of MRD in AML demonstrates that blast phenotypes consistently show abnormalities but may evolve during treatment, emphasizing the importance of comprehensive antigen panel analysis for accurate detection.
Hematology February 20th 2025